Related Experiment Video
Updated: Oct 7, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Glomerular growth under cyclosporine treatment in childhood nephrotic syndrome
1Department of Pathology, Yonsei University College of Medicine, Seoul, Korea. jeong10@yumc.yonsei.ac.kr
Insights
Cyclosporine (CsA) treatment in children with nephrotic syndrome can hinder glomerular growth, potentially leading to kidney damage. Impaired growth is linked to treatment duration and tubulointerstitial lesions (TIL).
Area of Science:
- Pediatric Nephrology
- Renal Pathology
- Pharmacology
Background:
- Glomerular hypertrophy is a key factor in pediatric idiopathic nephrotic syndrome (INS) pathogenesis and diagnosis.
- Cyclosporine (CsA) is used to treat INS, but its effect on glomerular growth is not fully understood.
Purpose of the Study:
- To investigate the impact of CsA treatment on glomerular growth in children with INS.
- To assess the relationship between glomerular morphometry, treatment duration, and adverse renal outcomes.
Main Methods:
- Morphometric analysis of Bowman's area (BA) and glomerular tuft area (GA) in pre- and post-treatment kidney biopsies from 47 children with INS (MCD and FSGS).
- Patients received CsA and low-dose prednisolone for up to 2 years.
Main Results:
- Glomerular areas (BA and GA) increased with age and were larger in FSGS compared to MCD.
- CsA treatment led to a decrease in BA and GA in a significant proportion of patients (48.9% and 40.4%, respectively).
- Development of tubulointerstitial lesions (TIL) was observed in 27.7% of cases, with greater glomerular area reduction in these children.
Conclusions:
- CsA treatment can impair glomerular growth in children with INS, a complication more frequent than TIL.
- The degree of glomerular growth impairment is associated with treatment duration and the presence of TIL.
- Age and specific diagnosis (MCD vs. FSGS) did not influence the impairment of glomerular growth.
Background:
Glomerular hypertrophy is important in children with idiopathic nephrotic syndrome in regard to diagnosis and pathogenesis. Moreover, glomerular growth may be altered by cyclosporine (CsA) treatment in these patients.
Methods:
Bowman's area (BA) and the glomerular tuft area (GA) of pre- and post-treatment biopsies was measured by morphometry in 47 children with idiopathic nephrotic syndrome (39 MCD and 8 FSGS) treated with CsA and low-dose prednisolone for up to 2 years.
Results:
BA and GA increased with age. The mean BA and GA were 1.2 times larger in FSGS than in MCD and the proportional increase was similar in both diseases after treatment. BA and GA decreased in 48.9% and 40.4% of cases after treatment, respectively, whereas tubulointerstitial lesion (TIL) developed in 27.7%. BA and GA decreased to 10.4% and 8.3%, respectively in children who developed TIL after treatment and the values were largely unchanged in those treated for more than 16 months.
Conclusions:
Glomerular growth is hampered by CsA nephrotoxicity, which is a more common complication than TIL. The impairment of glomerular growth is related to the duration of treatment and the development of TIL, but not to age or diagnosis.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Pharmacokinetics in Pediatric Patients: Drug Excretion
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
